From Bench to Bedside: The Journey of Oligonucleotide Drug Development and Sterile Filling

About this white paper:

This white paper serves as a comprehensive guide to enhancing the formulation, lyo cycle development, and fill finish process of oligonucleotide therapeutics. The paper will describe the latest strategies and best practices for improving the quality and efficacy of oligo drug products. From identifying key factors in formulation development to optimizing the lyophilization process and ensuring sterile fill finish, this whitepaper provides valuable insights for researchers, scientists, and pharmaceutical professionals looking to stay ahead in this rapidly evolving field.

This white paper discusses how oligonucleotide drug product formulations are developed and optimized, the process of developing and optimizing a lyophilization cycle, how drug product sensitivities are managed through formulation, filtration, and filling, and simple and effective solutions to reduce drug product loss.

Download Oligonucleotide Whitepaper

From Bench to Bedside

Name(Required)

First name Last name

Email(Required)

Company(Required)

At Sharp, we always have exciting pharma topics that we’d like to share with you. We will only contact you about topics that we think might be of interest, based on the information you provide to us.

Yes, I’d like to receive email updates from Sharp based on my details [1]

[1] Sharp takes your privacy seriously and will only use your personal information to provide services that you have requested from us. We will not share your personal information with non-agent third parties. View our privacy policy here.

This field is hidden when viewing the form

utm_source

This field is hidden when viewing the form

utm_medium

This field is hidden when viewing the form

utm_campaign